Trial Profile

Clinical Trials Insight: 700016056

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 11 Jan 2008

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Resveratrol (Primary)
Indications Type 2 diabetes mellitus
Focus Adverse reactions; Pharmacokinetics
Sponsors Sirtris

Most Recent Events

08 Jan 2008 Status change from initiated to in progress, from a Sirtis media release.
08 Jan 2008 Interim results were reported by Sirtris Pharmaceuticals in a media release.
07 Jan 2008 Interim results were presented at the JPMorgan Healthcare Conference 2008.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com